English
简体中文
Total: £ 56.28
2025-08-12 | Pages: 90 | Tables: 88
The global market for Heparin API was valued at US$ 1225 million in the year 2024 and is projected to reach a revised size of US$ 2301 million by 2031, growing at a CAGR of 7.8% during the forecast period.The 2025 U.S. tariff policies introduce profo...
2025-08-12 | Pages: 82 | Tables: 81
The global market for Drugs for Altitude Sickness was valued at US$ 420 million in the year 2024 and is projected to reach a revised size of US$ 564 million by 2031, growing at a CAGR of 4.2% during the forecast period.Drugs for altitude sickness are...
2025-08-12 | Pages: 137 | Tables: 128
The global market for Lipid/Fat Emulsion was valued at US$ 3500 million in the year 2024 and is projected to reach a revised size of US$ 6821 million by 2031, growing at a CAGR of 10.0% during the forecast period.The 2025 U.S. tariff policies introdu...
2025-08-11 | Pages: 70 | Tables: 73
The global market for Recombinant Human Thrombin (rhThrombin) was valued at US$ 251 million in the year 2024 and is projected to reach a revised size of US$ 331 million by 2031, growing at a CAGR of 4.1% during the forecast period.The 2025 U.S. tarif...
2025-08-11 | Pages: 86 | Tables: 83
The global market for Fibrinogen for Injection was valued at US$ 468 million in the year 2024 and is projected to reach a revised size of US$ 753 million by 2031, growing at a CAGR of 7.2% during the forecast period.The 2025 U.S. tariff policies intr...
2025-08-11 | Pages: 109 | Tables: 113
The global market for Drug-containing Fat Emulsion was valued at US$ 2300 million in the year 2024 and is projected to reach a revised size of US$ 5085 million by 2031, growing at a CAGR of 12.0% during the forecast period.The 2025 U.S. tariff polici...
2025-08-08 | Pages: 79 | Tables: 77
The global Reteplase market size was US$ 11.7 million in 2024 and is forecast to a readjusted size of US$ 8.9 million by 2031 with a CAGR of -3.7% during the forecast period 2025-2031. By 2025, the evolving U.S. tariff policy is poised to inject cons...
2025-08-08 | Pages: 122 | Tables: 129
The global Vaginitis Drug market size was US$ 2746 million in 2024 and is forecast to a readjusted size of US$ 4063 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.Vaginitis is an inflammation of the vaginal mucosa and submuc...
2025-08-08 | Pages: 76 | Tables: 76
The global Doxorubicin Hydrochloride market size was US$ 58.8 million in 2024 and is forecast to a readjusted size of US$ 91.5 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031. By 2025, the evolving U.S. tariff policy is poise...
2025-08-08 | Pages: 104 | Tables: 105
The global Propofol Drug market size was US$ 1400 million in 2024 and is forecast to a readjusted size of US$ 1761 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031. By 2025, the evolving U.S. tariff policy is poised to inject ...
2025-08-08 | Pages: 66 | Tables: 75
The global Yttrium-90 Microspheres market size was US$ 191 million in 2024 and is forecast to a readjusted size of US$ 397 million by 2031 with a CAGR of 11.2% during the forecast period 2025-2031. By 2025, the evolving U.S. tariff policy is poised t...
2025-08-08 | Pages: 107 | Tables: 101
The global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market size was US$ 410 million in 2024 and is forecast to a readjusted size of US$ 521 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031. By 2025, the evo...
2025-08-08 | Pages: 79 | Tables: 76
The global Diabetes Stem Cell Therapy market size was US$ 127 million in 2024 and is forecast to a readjusted size of US$ 3180 million by 2031 with a CAGR of 59.3% during the forecast period 2025-2031.North America key players of Diabetes Stem Cell T...
2025-08-08 | Pages: 87 | Tables: 83
The global market for Arg34GLP-1(9-37) was valued at US$ 91.0 million in the year 2024 and is projected to reach a revised size of US$ 572 million by 2031, growing at a CAGR of 28.0% during the forecast period.The 2025 U.S. tariff policies introduce ...
2025-08-07 | Pages: 79 | Tables: 77
The global Synthetic Peptide Vaccine market size was US$ 115 million in 2024 and is forecast to a readjusted size of US$ 189 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031. By 2025, the evolving U.S. tariff policy is poised ...
